Avoro Capital Advisors LLC Madrigal Pharmaceuticals, Inc. Call Options Transaction History
Avoro Capital Advisors LLC
- $6.18 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MDGL
# of Institutions
363Shares Held
23.4MCall Options Held
965KPut Options Held
419K-
Janus Henderson Group PLC London, X02.21MShares$792 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$754 Million39.89% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$716 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$709 Million7.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$674 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $6.14B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...